TPD52 |
TPD52: Tumor protein D52 |
TPD52L3 |
IPI00306317 |
128.000 |
Evidence |
|
TPD52L1 |
TPD52L1: Tumor protein D53 |
TPD52 |
TPD52: Tumor protein D52 |
128.000 |
Evidence |
O
|
TPD52L1 |
TPD52L1: Tumor protein D53 |
TPD52L3 |
IPI00306317 |
128.000 |
Evidence |
|
PROC |
PROC: Vitamin K-dependent protein C precursor |
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
128.000 |
Evidence |
O
|
F8 |
F8, F8C: Coagulation factor VIII precursor |
PROS1 |
PROS1, PROS: Vitamin K-dependent protein S precursor |
128.000 |
Evidence |
O
|
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
HLA-DRA |
|
128.000 |
Evidence |
|
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
HLA-DRA |
|
128.000 |
Evidence |
|
CSE1L |
CSE1L, CAS, XPO2: Exportin-2 |
KPNB1 |
KPNB1, NTF97: Importin subunit beta-1 |
125.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
125.000 |
Evidence |
|
F7 |
F7: Coagulation factor VII precursor |
GGCX |
GGCX, GC: Vitamin K-dependent gamma-carboxylase |
125.000 |
Evidence |
|
POLR2D |
POLR2D: DNA-directed RNA polymerase II subunit RPB4 |
POLR2G |
POLR2G: DNA-directed RNA polymerase II subunit RPB7 |
123.000 |
Evidence |
|
POLR2H |
POLR2H: DNA-directed RNA polymerases I, II, and III subunit RPABC3 |
POLR2L |
POLR2L: DNA-directed RNA polymerases I, II, and III subunit RPABC5 |
123.000 |
Evidence |
|
CHEK1 |
CHEK1, CHK1: Serine/threonine-protein kinase Chk1 |
LSM1 |
LSM1, CASM: U6 snRNA-associated Sm-like protein LSm1 |
123.000 |
Evidence |
O
|
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
122.000 |
Evidence |
O
|
PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
121.000 |
Evidence |
|
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
121.000 |
Evidence |
|
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
121.000 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
121.000 |
Evidence |
|
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
121.000 |
Evidence |
|
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
121.000 |
Evidence |
|
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
121.000 |
Evidence |
|
GYG2 |
GYG2: Glycogenin-2 |
GYS1 |
GYS1, GYS: Glycogen [starch] synthase, muscle |
121.000 |
Evidence |
|
MYF5 |
MYF5: Myogenic factor 5 |
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
121.000 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
121.000 |
Evidence |
O
|
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
119.000 |
Evidence |
O
|